Articles / New research on countering superbugs
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
Antibiotic resistance is by no means a new problem, but the latest CDC report into the phenomenon does outline some novel approaches to treating bacterial infection.
The advice for slowing infections generally and resistance in particular will be familiar: vaccination, strict hygiene for medical facilities and personnel, and using antibiotics only when needed and for the shortest duration possible. The authors admit that these are only temporary measures however, especially given that some bacteria are now becoming resistant to disinfectants as well.
Researchers are also working to develop new types of antibiotics to combat drug resistant bacteria, although most of these efforts are in the early stages. In the shorter term, research has indicated that using specific combinations of existing antibiotics can be effective where current therapies fail.
Donanemab – A GP Guide to Anti-Amyloid Therapies
LDL and Cardiovascular Disease
Early Menopause
Autism Spectrum Disorder in Children
Within the next 12 months
Within the next 3 years
Within the next 5 years
Within the next 10 years
More than 10 years
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease